These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 23781066)

  • 1. An Escherichia coli effector protein promotes host mutation via depletion of DNA mismatch repair proteins.
    Maddocks OD; Scanlon KM; Donnenberg MS
    mBio; 2013 Jun; 4(3):e00152-13. PubMed ID: 23781066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enteropathogenic Escherichia coli dynamically regulates EGFR signaling in intestinal epithelial cells.
    Roxas JL; Ryan K; Vedantam G; Viswanathan VK
    Am J Physiol Gastrointest Liver Physiol; 2014 Aug; 307(3):G374-80. PubMed ID: 24904077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial Targeting of the Enteropathogenic Escherichia coli Map Triggers Calcium Mobilization, ADAM10-MAP Kinase Signaling, and Host Cell Apoptosis.
    Ramachandran RP; Spiegel C; Keren Y; Danieli T; Melamed-Book N; Pal RR; Zlotkin-Rivkin E; Rosenshine I; Aroeti B
    mBio; 2020 Sep; 11(5):. PubMed ID: 32934081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The enteropathogenic E. coli effector EspF targets and disrupts the nucleolus by a process regulated by mitochondrial dysfunction.
    Dean P; Scott JA; Knox AA; Quitard S; Watkins NJ; Kenny B
    PLoS Pathog; 2010 Jun; 6(6):e1000961. PubMed ID: 20585567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. E. coli secreted protein F promotes EPEC invasion of intestinal epithelial cells via an SNX9-dependent mechanism.
    Weflen AW; Alto NM; Viswanathan VK; Hecht G
    Cell Microbiol; 2010 Jul; 12(7):919-29. PubMed ID: 20088948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EspZ of enteropathogenic and enterohemorrhagic Escherichia coli regulates type III secretion system protein translocation.
    Berger CN; Crepin VF; Baruch K; Mousnier A; Rosenshine I; Frankel G
    mBio; 2012; 3(5):. PubMed ID: 23033475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The EspF effector, a bacterial pathogen's Swiss army knife.
    Holmes A; Mühlen S; Roe AJ; Dean P
    Infect Immun; 2010 Nov; 78(11):4445-53. PubMed ID: 20679436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting of enteropathogenic Escherichia coli EspF to host mitochondria is essential for bacterial pathogenesis: critical role of the 16th leucine residue in EspF.
    Nagai T; Abe A; Sasakawa C
    J Biol Chem; 2005 Jan; 280(4):2998-3011. PubMed ID: 15533930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enteropathogenic E. coli-induced barrier function alteration is not a consequence of host cell apoptosis.
    Viswanathan VK; Weflen A; Koutsouris A; Roxas JL; Hecht G
    Am J Physiol Gastrointest Liver Physiol; 2008 May; 294(5):G1165-70. PubMed ID: 18356531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EspFu-Mediated Actin Assembly Enhances Enteropathogenic
    Martins FH; Kumar A; Abe CM; Carvalho E; Nishiyama-Jr M; Xing C; Sperandio V; Elias WP
    mBio; 2020 Apr; 11(2):. PubMed ID: 32291304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EPEC effector EspF promotes Crumbs3 endocytosis and disrupts epithelial cell polarity.
    Tapia R; Kralicek SE; Hecht GA
    Cell Microbiol; 2017 Nov; 19(11):. PubMed ID: 28618099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The N-terminal domain of EspF induces host cell apoptosis after infection with enterohaemorrhagic Escherichia coli O157:H7.
    Zhao S; Zhou Y; Wang C; Yang Y; Wu X; Wei Y; Zhu L; Zhao W; Zhang Q; Wan C
    PLoS One; 2013; 8(1):e55164. PubMed ID: 23372831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enteropathogenic E. coli effectors EspF and Map independently disrupt tight junctions through distinct mechanisms involving transcriptional and post-transcriptional regulation.
    Singh AP; Sharma S; Pagarware K; Siraji RA; Ansari I; Mandal A; Walling P; Aijaz S
    Sci Rep; 2018 Feb; 8(1):3719. PubMed ID: 29487356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enteropathogenic
    Roxas JL; Ramamurthy S; Cocchi K; Rutins I; Harishankar A; Agellon A; Wilbur JS; Sylejmani G; Vedantam G; Viswanathan VK
    Gut Microbes; 2022; 14(1):2143224. PubMed ID: 36476073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The enteropathogenic Escherichia coli effector protein EspF decreases sodium hydrogen exchanger 3 activity.
    Hodges K; Alto NM; Ramaswamy K; Dudeja PK; Hecht G
    Cell Microbiol; 2008 Aug; 10(8):1735-45. PubMed ID: 18433466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamics of expression, secretion and translocation of type III effectors during enteropathogenic Escherichia coli infection.
    Serapio-Palacios A; Finlay BB
    Curr Opin Microbiol; 2020 Apr; 54():67-76. PubMed ID: 32058947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential role of Escherichia coli DNA mismatch repair proteins in colon cancer.
    Khan S
    Crit Rev Oncol Hematol; 2015 Dec; 96(3):475-82. PubMed ID: 26014615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tight junctions and enteropathogenic E. coli.
    Weflen AW; Alto NM; Hecht GA
    Ann N Y Acad Sci; 2009 May; 1165():169-74. PubMed ID: 19538303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EspF Interacts with nucleation-promoting factors to recruit junctional proteins into pedestals for pedestal maturation and disruption of paracellular permeability.
    Peralta-Ramírez J; Hernandez JM; Manning-Cela R; Luna-Muñoz J; Garcia-Tovar C; Nougayréde JP; Oswald E; Navarro-Garcia F
    Infect Immun; 2008 Sep; 76(9):3854-68. PubMed ID: 18559425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topology and function of translocated EspZ.
    Haritan N; Bouman EA; Nandi I; Shtuhin-Rahav R; Zlotkin-Rivkin E; Danieli T; Melamed-Book N; Nir-Keren Y; Aroeti B
    mBio; 2023 Aug; 14(4):e0075223. PubMed ID: 37341483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.